Jing Ji
Chief Medical Officer & Executive DirectorDr. Jing Ji serves as Chief Medical Officer at Abbisko Therapeutics Co. Ltd. since February 2021. Dr. Ji serves as Chief Medical Officer of Abbisko Medicine Co., Ltd. (formerly known as Abbisko Cayman Limited) since February 1, 2021 and also serves as its Executive Director since March 3, 2025. Prior to joining Abbisko, she was the SVP and Head of Medical and Clinical Development at Shanghai Lianbio Development Co., Ltd., from May 2020 to January 2021, where she successfully led several IND submissions and approvals within a relatively short period of time. Previously, she served as Vice President and Head of Cardiovascular, Renal and Metabolism Therapeutic Area and Head of Clinical Pharmacology and Drug Safety at AstraZeneca China from April 2015 to May 2020. In this role, she was responsible for China development strategy and execution for AstraZeneca's CV, renal and metabolic projects and led key academic collaborations with top research centers. From January 2010 to April 2015, Dr. Ji served at Johnson & Johnson Medical (Shanghai) Ltd. From June 2006 to January 2010, Dr. Ji served as the head of medical affairs at GlaxoSmithKline plc, a pharmaceutical company engaged in the development, manufacture and marketing of pharmaceutical products. Her industry career also included senior positions as Director of Exploratory Medicine at Johnson Johnson China, Head of Clinical and Scientific Affairs at GSK, as well as Head of Clinical Research Unit of Sanofi-Aventis and MSD from September 2003 to September 2005. Prior to her career in the industry, she began her career as a practicing physician for approximately four years. She served as the clinical research manager at Merck Sharp & Dohme, a pharmaceutical company engaged in the development of vaccines, medicines and health products, from December 1997 to March 2003. Dr. Ji worked as a doctor at Shanghai First People’s Hospital from July 1995 to December 1997. Dr. Ji has a strong track record and experience in drug development, portfolio management and other areas of clinical development for innovative medicines. She is a highly experienced leader having held a number of senior executive roles at top tier pharmaceutical and biotech companies. Dr. Ji obtained her Bachelor of Medicine degree from Fudan University and Shanghai Second Medical University in the PRC in July 1993 and Master’s degree in medicine from Fudan University and Shanghai Second Medical University in the PRC in July 1995.
Positions
- Company NameAbbisko Medicine Co., Ltd.Stock Code02256PositionChief Medical Officer & Executive DirectorColleagues
- YXYao-Chang XuFounder, Executive Chairman of the Board & CEO
- HYHongping YuCo-Founder, SVP of Chemistry, Chief Scientific Officer & Executive Director
- JFJia FengVP of HR and Operations & Head of Human Resource
- YLYongyi LiGeneral Counsel
- HSHongbin SunIndependent Non-Executive Director
- HYHoi Yam ChuiIndependent Non-Executive Director
